Peter Kühnen, n/a

Charite Universitaetsmedizin Berlin
Berlin, Germany

Disclosure information not submitted.

Presentation(s):

• ORF10-06 - Ersodetug (RZ358) in Congenital Hyperinsulinism: Top-Line Results from a Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study (sunRIZE)

  Saturday, June 13, 2026
  2:30 PM - 2:45 PM CT

• SY28-03 - Setmelanotide/therapeutic Targeting of Melanocortin Receptors: From Drug Development to Clinical Application

  Sunday, June 14, 2026
  11:30 AM - 12:00 PM CT

• MON-704 - Biased Signaling of Melanocortin 4 Receptor and Associations with Increased or Reduced Body Weight

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT

• ORF50-01 - Biased Signaling of Melanocortin 4 Receptor and Associations with Increased or Reduced Body Weight

  Monday, June 15, 2026
  1:45 PM - 1:50 PM CT